Embed Size (px)
Citation preview
Asbestos and the Law Conference 2014Deidre’s StoryArmley: The UK’s Deadliest District (Part 4)The Royal British Legion Profile
In this issue
Issue 5January 2015
www.asbestosjustice.co.uk0800 038 67672
Contents Welcome2 Patient Perspectives Your questions answered
3 Asbestos & the Law Conference 2014
6 Clinical Trials Verastem
7 Benefit Entitlements Personal Independence Payment (PIP)
8 Armley The UK’s Deadliest District - Part 4
9 Deidre’s Story
10 Social Media Trending news
Organisation profile- The Royal British Legion
11 Treatment Centres Asbestos disease treatment in the UK
2014 was a year of revelation for asbestos disease sufferers and associated professionals.
Justice was served for mesothelioma sufferers as The Ministry of Justice upheld the decision for sufferers to keep all of their compensation damages. The Saatchi Bill was finally backed by the government, allowing sufferers searching for a cure to participate in groundbreaking trials and I attended the 2014 Asbestos and the Law Conference in Liverpool. It was a fantastic event perfectly organised by the Merseyside Asbestos Victims Support Group.
Our November edition graced us with one woman’s unedited account of her husband’s battle with mesothelioma and their journey through his diagnosis and treatments. Their story created an incredible outpouring of support and empathy from the asbestos community worldwide.
In January’s issue we’ve strived to deliver real-life stories, a clear perspective on topical issues and a host of practical advice. With so many ground-breaking events taking place for asbestos sufferers, we believe 2015 will truly be a year for Justice.
Helena Cameron. Asbestos Justice Associate Director
Helena Cameron
Denise Andreacchi: “My mother and I
had never heard about this diagnosis.
My dad was a very healthy man.
He went to the hospital for tummy
issues. We got told Oct 30th and he
passed away Nov 14th. We had two
weeks but we brought him home.
Even the doctors were shocked at how
aggressive it was. Since then I have
learned a lot. Many companies do
not care, I was told that my dad never
existed. However we are all strong and
will continue to fight for our loved ones”.
Mavis Nye: “Diagnosed in 2009 I wish
they didn’t try to give a prediction of
when you will die. We are all different
our DNAs, our exposure, and our ability
to fight are all different and to be told 3
months to live is absolutely devastating”.
Contribute
Subscibe
If you would like to share your story with us, or contribute towards our next issue of Justice, please email: [email protected]
If you would like to subscribe to our FREE Justice newsletter, please email: [email protected] month we’re featuring a Q&A session from members of the
asbestos community.
“When you or your loved one were diagnosed, what do you feel could have been handled differently by your consultant?”
Ask the Patient
Last October I travelled to the Merseyside Asbestos Victims Support Group Conference 2014 at the Liverpool Maritime Museum. I had been previously a few years ago but did not realise what a fulfilling and inspiring day was ahead of me.
The day began with a DVD presentation by Robert Vojakovic, the President of the Australian Asbestos Diseases Society who is based in Perth.
Robert had spent time in the 1960’s working at the infamous CSR blue asbestos mine at Wittenoom. During the 1970s he became aware of a lack of support for former Wittenoom miners and other asbestos disease sufferers and in the early 1980’s he formed the Asbestos Disease Society of Australia
3
Asbestos and the Law Conference, Liverpool 2014
(ADSA) in Western Australia. Robert has dedicated the last 28 years presiding over the ADSA and managing the Asbestos Diseases Advisory Services of Australia.
Through these organisations he has provided essential services and support to victims of asbestos diseases and their families throughout Australia. Such services have included counselling, medical and legal assistance, community awareness and economic assistance. He has also successfully lobbied the government to change the Statutory Compensation Laws, the Limitation Act and the entitlements to
families in the matters of estate and dependency.
The presentation provided an insight into the mining and use of asbestos in Australia with discussion of the mining at Wittenoom together with details as to the effects that this asbestos exposure had had on communities. Robert provided us with details of the incidence of asbestos disease in Australia stating that there have already been over 20,000 deaths due
to the inhalation of asbestos fibres and confirmed that it was estimated that a further 15,000 would die by the year 2015.
He showed us some rather haunting photographs of the workers at Wittenoom, most of whom had since died of mesothelioma. The photographs showed happy, fit and young workers. How tragic to think what their hard work would lead to.
Following the DVD, delegates at the conference then had the fantastic opportunity to ask Robert questions over a live video link to Perth. Tony Whitson, the Chairman of the Asbestos Victims Support Groups, asked about what government support was available for mesothelioma research in Australia. Robert confirmed that there had been very little money in the last 10 years for research and that money had mainly been raised through fundraising. Questions were asked about the Australian legal system for dealing with asbestos disease claims and the Australian approach to dealing with asbestos still present in buildings.
If the course had ended at this point I would have felt satisfied but this was only the beginning of the day.
Asbestos Justice’s Associate Director, Helena Cameron, was at this year’s Asbestos and the Law Conference in Liverpool.
Robert Vojakovic
www.asbestosjustice.co.uk0800 038 67674
The next speaker was asbestos disease specialist Barrister, Simon Kilvington, from Byrom Street Chambers in Manchester. He provided a full update as to the legal position in asbestos disease claims. He referred to recent cases and discussed the implications for asbestos disease cases going forward. At Asbestos Justice, Simon Kilvington is our preferred barrister. With his expertise we know that our clients are getting the best advice and representation.
Simon has been involved in a number of very high profile asbestos disease cases and his experience is extensive. The update was very comprehensive and as there were a lot of solicitors at the conference it was very welcome.
The morning then moved from a legal emphasis to more of a political emphasis with talks from Lord David Alton of Liverpool, an Independent Crossbench Life Peer, and Kate Green, MP for Stretford & Urmston, Shadow Minister of State for Work & Pensions.
Lord Alton has recently campaigned tirelessly on trying to introduce amendments to the Mesothelioma Bill (enacted in April 2014) for provisions to be made for research into finding a cure for mesothelioma. He has also argued that mesothelioma sufferers are not to blame for rising compensation claims and should not have to pay additional legal costs. He discussed the real need for an increase in the funding for mesothelioma research outlining that the UK has the highest rate of mesothelioma in the world. He commented that relatively little is spent on mesothelioma research in the UK measured against other cancers.
For example, in 2012 the National Cancer Research Institute reported
that £1.2m was invested in mesothelioma research, a sum significantly lower that the £9.9m and £5.3m spent on skin cancer/melanoma and myeloma, two cancers that cause a similar number of deaths each year. Part of Lord Alton’s campaign to increase mesothelioma funding research involved a proposed amendment to the Mesothelioma Bill to include provision for a small additional levy on insurance companies active in the Employers’ Liability insurance market. This had the potential to raise a further £1.5m per year for mesothelioma research but sadly the amendment was narrowly defeated.
Campaigning continues with discussions with the ABI (Association of British Insurers) to try and introduce a voluntary levy but nothing has been secured as yet. Lord Alton went onto discuss the agreement reached between the British Lung Foundation and four leading insurance
companies in 2010. This agreement saw them collectively grant £1m a year for three years to invest predominantly in research into mesothelioma and potential cures. The results have been impressive. Research specialists have started taking an interest in the disease, bringing new expertise and insights.
Europe’s first mesothelioma tissue bank has been created to collect and store biological tissue from mesothelioma patients for use in research and a trans-Atlantic collaboration to map the genetic architecture of the disease is now being funded. This will be a crucial step to finding a cure. However, it remains a real concern that funding will not be forthcoming unless there is specific legislation to formalise the insurance industry’s duty to contribute. Campaigning continues.
Kate Green MP continued the political theme by outlining the intentions of the Labour Party with regards to mesothelioma, dealing with the disease and funding for research. Criticism was made of the ABI and the way it has approached asbestos disease claims and mesothelioma research funding.
Lord David Alton of Liverpool
Kate Green MP
5
To provide the other side of the argument, James Dalton, the Head of Motor and Liability at the ABI (Association of British Insurers) was then welcomed to the podium. The welcome was relatively short lived given the significant number of people in the room representing the interests of mesothelioma sufferers and claimants. He attempted, but miserably failed, to convince the audience, including some mesothelioma sufferers themselves, that the only thing holding back claims for mesothelioma was Claimant Solicitors and their wish to profit from such claims.
He talked about the efforts the insurance industry had made to collect insurance records to ensure that people trying to claim knew where to direct their claim. It was accepted by the audience that the introduction of this more comprehensive register (ELTO) was a good thing but was criticised for the fact that it had not been introduced years ago.
James stated that as a representative for the insurance industry he was not opposed to a levy for insurance research but when asked whether he agreed with it and what his views were on how this would be introduced and at what level, he refused to comment further. Needless to say the questions and answer session following his presentation was rather longer than with any of the other speakers.
In a room with a good number of Claimant solicitors and asbestos support group representatives, there was outrage at his comments and views, and the temperature in the room certainly rose.
After the rather heated and long debate we all adjourned for a leisurely (albeit late) lunch. I had the absolute pleasure of sitting next to and enjoying lunch with a lovely couple from Prenton. Sadly the husband was suffering with mesothelioma and had come to the conference with his wife to show his continued support for the efforts of the support groups. They told me that they came to the conference every year and it was clear that they were pleased to be a part of the community. We talked about the course but then chatted about the holidays that they had enjoyed and still enjoyed together. The gentleman was 4 years post diagnosis and his positive attitude was inspiring.
After lunch, Harry Steinberg, a barrister at 12 Kings Bench Walk Chamber, London, gave an insight into the new Diffuse Mesothelioma Payment Scheme which came into force on 6th April 2014. He outlined the intention of the scheme to provide compensation for mesothelioma sufferers who have contracted the disease but who cannot trace the guilty employer or its liability insurers.
He discussed the way the scheme worked and those that would be eligible under the scheme. This is a scheme which will hopefully plug some of the gaps caused by companies going out of business and insurance records not being capable of being traced.
To complete the picture, the conference ended with Dr. Chris Warburton, Clinical Director and Consultant Respiratory Physician at Aintree Chest Centre, who provided the medical perspective and discussed the current debates on medical aspects of asbestos related diseases. With many of the medical aspects of asbestos related disease being well versed, he discussed the newer and potentially more controversial aspects of asbestos related disease.
He covered the effect of low dose asbestos on lung fibrosis risk, newer studies regarding lung cancer and asbestos exposure and newer treatments for mesothelioma. Dr. Warburton is a great medical speaker using x-ray and scan images to explain clearly complex medical issues.
Final Thoughts
I came away from the conference with a real sense of community.
Despite the efforts of the insurance industry to paint what we do as simply a profit making scheme, I realised that we do a good and honest job for good and honest people and I felt proud to be a part of the community. I am looking forward to next year’s conference already!
James Dalton
Dr. Chris Warburton
www.asbestosjustice.co.uk0800 038 67676
Cancer stem cells are an underlying cause of tumour recurrence and metastasis. The majority of cancer drugs, while killing the bulk of tumour cells, ultimately fail to induce durable clinical responses because these cells develop a resistance to treatment over time. A reason for this acquired resistance may be the presence of small minority of cells in the tumour called cancer stem cells (CSC). These CSCs are often resistant to existing cancer therapies including targeted drugs, chemo- and radiation therapy.
Standard approach
The CSCs within tumours have the capacity to regenerate the primary tumour. They also acquire characteristics that increase their invasive potential. The ability of CSCs to move to other sites in the body, combined with the capability to initiate a new tumour mass, may implicate CSCs as an important factor in the formation of metastases. Metastatic tumour sites are the cause
of death in more than 90% of human cancer patients. Cancer stems cells have been found in many types of tumours, including leukaemia, myeloma, breast, prostate, colon, brain, lung and other cancers.
In order to develop truly effective treatments that can create a durable clinical response it is important to develop drugs that can target and kill CSCs. A major factor that has prevented the discovery of drugs targeting CSCs is that isolated CSCs rapidly differentiate in culture, yielding the non-CSCs that represent the majority of cells in tumours.
Verastem’s approach
Verastem’s proprietary research has developed a system for the discovery of
a new generation of cancer drugs that can selectively target CSCs and provide a strategy for treatment of cancer patients. This has been accomplished by developing novel methods to create large numbers of cells that stably reside within the cancer stem-cell state. By engineering tumour cells to stably transition to CSCs, Verastem has established high-throughput drug discovery systems that make it possible to identify and develop drugs specifically targeting CSCs.
Our technology identifies drugs that are able to target and kill cancer stem cells thereby reducing the initiation of new tumours.
Full credit to: Verastem.com
Consultant Profile
Dr Peter SzlosarekDr Peter Szlosarek is a Clinical Senior Lecturer and Consultant in Medical Oncology at the Barts Cancer Institute (QMUL) and St. Bartholomew’s Hospital.
Dr Szlosarek trained in London teaching hospitals, and was awarded
a PhD degree in translational cancer medicine from the University of London. His post-doctoral work is focused on the role of abnormal cancer metabolism involving the amino acid arginine.
His main clinical interests are in melanoma, lung cancer and mesothelioma, with a particular emphasis on targeted drugs and metabolic and immunotherapeutic approaches. He is a chief and principal investigator of novel anticancer drugs and is a member of several professional bodies, including London Cancer for
which he is a clinical and research lead. Dr Szlosarek is involved in both undergraduate and postgraduate education with publications in Cancer Research, Clinical Cancer Research, Lancet Oncology and Journal of Clinical Oncology. His work has been presented at various international conferences with invited lectures in the US, Europe and Asia.
E-Mail Secretary: Katherine [email protected]
Source: Leaders in Oncology Care. http://www.theloc.com/
Clinical trials
Benefit EntitlementsThere are numerous state benefits which you may be able to claim if your asbestos related disease was caused whilst in employment.
For Expert advice call 0800 038 6767.
What is it?
PIP helps with some of the extra costs caused by long-term ill-health or disability if you suffer with an asbestos related condition and are aged under 65 years old. This benefit replaced the Disability Living Allowance on the 8th April 2013 for disabled people aged between 16 and 64 years of age.
Am I eligible to claim PIP?
You will need to undergo an assessment to work out the level of help you receive. Your award will be assessed regularly to ensure you are receiving the right level of support.
To qualify for PIP, you must:
• be aged 16 to 64
• have a long-term health condition or disability and difficulties with activities related to ‘daily living’ and or mobility (see below)
• be in Great Britain when you claim - there are some exceptions, e.g. members and family members of the Armed Forces
• have been in Great Britain for at least 2 of the last 3 years
• be a habitual resident in the UK, Ireland, Isle of Man or the Channel Islands
• not be subject to immigration control (unless you’re a sponsored immigrant)
What will I receive if my application is successful?
Successful applicants for PIP will receive varying amounts of money, made up from 2 component parts, called the “daily living component” and the “mobility component”.
Daily Living Component
This part of the benefit can be paid to asbestos disease sufferers if they:-
• require assistance with day to day tasks such as eating and preparing meals, using the toilet, dressing and washing etc.
• are terminally ill
• require supervision to avoid putting themselves and others in substantial danger
• require assistance in preparing or eating food
• experience problems in reading and communicating
• require assistance in managing medicines or treatments
• require assistance about making decisions about money
• experience problems in engaging with other people
The standard rate is £54.45 per week and this can be paid to sufferers who require some light assistance.
The enhanced rate of £81.30 per week is payable to those suffering with a terminal asbestos related illness such as Mesothelioma, and those who require help or supervision during the day or night.
Mobility Component
This part of the benefit can be paid to asbestos disease sufferers who, when using a normal aid:-
• are unable to walk
• can only walk short distances without suffering severe discomfort
• could become very ill if they try to walk
People may also receive the benefit if they:-
• have no feet or legs
• are assessed as 100% blind and at least 80% deaf and require assistance outdoors
• require supervision when outdoors
• are certified as severely sight impaired
• are severely mentally impaired with behavioural problems and receive the highest rate of care for DLA
The lowest rate payable is £21.55 per week and can be paid to sufferers who require general supervision outdoors. The highest rate payable is £56.75 to those experiencing severe difficulties in walking.
For further information on claiming PIP please contact Helena Cameron on 0800 038 6767 or email [email protected]
7
Personal Independence Payment (PIP)
Armley The UK’s Deadliest District
www.asbestosjustice.co.uk0800 038 67678
They found that children who attended the Clock School were at “increased risk of developing Mesothelioma because of ‘environmental’ exposure from the factory’ [7].
Of the 1077 children whose records were cross-examined and attended the school during 1927-1947, five had died at the average age of 46 from Mesothelioma during 1971 and 1987. Further investigation into the residential surrounding of the factory found that 125 males and 55 females had passed due to Mesothelioma between 1971 and 1987.
A study conducted in 1995 was based on the growing concern that the JW Roberts Factory was responsible for Mesothelioma deaths of both the workers and those who lived or attended the Clock School near the factory. The study looked at all Leeds-related Mesothelioma deaths occurring between 1971 and 1987.
The types of exposure (direct, indirect and environmental) were also used for classification; the reason was to identify clear links between the number of deaths and their form of exposure. www.asbestosjustice.co.uk/armley uks-deadliest-town
Mesothelioma Deaths in Leeds
Routes of exposure
OccupationalThose who had worked at the Armley factory 33 2 35 1Those in occupations elsewhere with likely exposureto asbestos 85 8 93 6
Household contactThose with a relative or close contact who hadworked at the Armley factory 13 2 15 13Those with a relative or close contact who had workedat other asbestos factories 1 0 1 0
UnknownThose where the occupation is unknown or was statedto be housewife 10 8 18 0
None knownThose in other occupations w ith no currentlyrecognised asbestos exposure 38 10 48 5
Total 180 30 210 25
Number of casesDied in Leeds (1)
Environmental cases**
Died elsewhere (2)*
Total(1 +2)
Number of cases
*Mesothelioma cases who were born in Leeds but who died elsewhere in England and Wales, between 1971 and 1987. **Mesothelioma cases labelled as ‘environmental’ by local coroner or media.Classification of Mesothelioma vases identified in the study by routes of asbestos exposure (Arblaster et al, 1995)
(Part 4)
9
Deidre’s StoryDeidre is the loving widow of her husband Thomas, who died from Pleural Mesothelioma in 1997. She created a site dedicated to her husband which shares the stories of those who have lost a family member as a result of an asbestos disease.
On the 7th January 1997 my husband Thomas C vanGerven was diagnosed with Pleural Mesothelioma.
We had never heard of it. All we were told was that it was a cancer of the lining of the lung and it was caused by asbestos. Another thing we knew nothing about. But the news that was by far the worst was that it was a death sentence. Thom was told to go home and to get his affairs sorted out as he was going to die. All hope was taken away from Thom that day. Four and a half months later on the 1st June he died.
Then began my search into mesothelioma and asbestos. I was appalled to find that because of sheer greed hundreds of thousands of people had died or were dying or are going to die in the future. That even though the dangers of asbestos had been known for many decades, people dealing with asbestos lied and cheated just so they could make a “buck”. And even now in this day and age they are still lying.
More than 5000 products contain or have contained asbestos, some of which are asbestos cement sheeting and pipe products used for water supply and sewage, piping, roofing and siding casings for electrical switchboards and components, and residential and industrial friction heat and electrical wire insulation materials.
Asbestos textile products, such as components, roofing materials, ceiling and floor tiling. It was used in a stipling compound that was used on the ceilings of 10,000s of New Zealand homes. “Thermal system insulation” sprayed or trowelled on “surfacing material” and vinyl or asphalt flooring is particularly likely to contain asbestos. Asbestos corrugated roofing. Products containing asbestos are still coming into our country. Because they are a manufactured article they are deemed safe so do not come under any regulations here in NZ. Try sawing, cutting or drilling into these products while building or renovating your home. You will not know which
products contained asbestos, but in 20, 30 40 plus years time when you are diagnosed with an asbestos related disease you can think back and take a guess which manufactured article had asbestos in it and is now killing you.
For asbestos fibres to be visible to the human eye there must be thousands
or even millions of fibres in the air, for
eg. When a drywall worker is sanding
down dried asbestos joint compound
or a pipe fitter is using a wire brush to
clean off pieces of an asbestos gasket
from a flange. In those instances,
millions of asbestos fibres are released
and that can be a sufficient quantity to
create an visible cloud of asbestos dust
in the air. It is scientifically accepted
that malignant mesothelioma can
be caused by relatively low doses of
asbestos, certainly even amounts of
asbestos that do not create visible
clouds of dust in the air. That’s one
of the aspects of mesothelioma that
makes it such an insidious disease.
New regulations on asbestos in NZ
do not cover products containing
asbestos or those people doing home
renovations. I cannot see why they
think that such a cavalier approach
to something that is quite serious to
the health of all of us is okay, It’s not
okay. All asbestos kills. It may not kill
everyone who comes in contact with
it. But you do not know who is going to
be the unlucky person. Will it be you?
Or will it be me?
To read more, visit Deidres’ website: www.fibreaware.org.nz
Thomas before diagnosis
Thomas after diagnosis
www.asbestosjustice.co.uk0800 038 676710
Social MediaWho to Follow Facebook Pages
Saatchi Bill
This page is used to inform, discuss and share opinions about the Medical Innovation Bill. The Bill will help doctors to innovate new treatments and cures safely and responsibly for cancer and other diseases.
Maximum Respect for the British Armed Forces and the RBL
The official supporter’s page for The Royal British Legion and the British Armed Forces community. Here you can share your views and positive messages of support for our Armed Forces family.
Global Ban Asbestos Network (GBAN)
The Global Ban Asbestos Network (GBAN) is a Social Media Community established to promote and facilitate collaboration and communication, increase awareness and achieve a global asbestos ban.
Linda Reinstein (@Linda_ADAO)
Mesothelioma widow dedicated to preventing asbestos-caused diseases through education, advocacy, and community action.
Mavis Rye (@grandmamavis)
Mesowarriors UK support group FB Patient Rep for the East Kent NHS Supporter of the Saatchi Bill- Activist My Blog is ttp://rayandmave.wordpress.com
Mesothelioma UK (@MesoUK)
Mesothelioma UK is a national resource centre dedicated to providing specialist Mesothelioma information, support & improved care and treatmentNHS Supporter of the Saatchi Bill- Activist My Blog is ttp://rayandmave.wordpress.com
Mesothelioma UK (@MesoUK)
Mesothelioma UK is a national resource centre dedicated to providing specialist Mesothelioma information, support & improved care and treatment.
Picture courtesy of The Royal British Legion
The Legion was founded by veterans after the First World War. A century on from the start of that conflict, we’re still helping today’s service men and women, veterans, and their families in almost every aspect of daily life. We’re also the nation’s custodian of Remembrance, safeguarding the memory of those who have given their lives for our freedom through Remembrance education and events.
WHO WE AREThe Legion is a big family - all supporting the Armed Forces community.• We are a benevolent charity giving help to those most in need;• A membership organisation providing support to 360,000 members; • A campaigning organisation challenging those in authority;• A fundraising organisation reliant on a huge network of volunteers;• The nation’s custodian of Remembrance
WHO WE HELP• We help serving members of the Royal Navy, Army and Royal Air Force• We also help ex-Service men and women, their carers and families• Millions of people in the UK and overseas are eligible to call on us for help• We aim to help the 500,000 most in need• Half the people we help are below retirement age
OUR SERVICESWhether it’s families coping with the loss of a loved one, help at home to
adapt to independent living, recovery centres for injured personnel, money and careers advice or residential care:
we are here to help.Millions of people in the UK and around the world are
eligible to access our welfare services and we aim to help the most in need.
As the legacy of Afghanistan and Iraq combine with defence cuts, strains on public sector support and a peak in welfare demand from older veterans; the Service community is facing a perfect storm of health and welfare needs in the coming years.
Picture courtesy of The Royal British Legion
Full credit to: britishlegion.org.uk
If you have been diagnosed with an asbestos disease, finding the right help can be difficult. Here are some of the UK’s top treatment and trial centres for asbestos disease. Many have been recognised for their survival success rates and pioneering treatments, so you’ll always be in safe hands.
11
Treatment Centres
Christie Hospital NHS Trust550 Wilmslow Road, Withington, ManchesterM20 4BX. Telephone: 0161 446 3000
The Christie Hospital NHS Trust is the largest single-site cancer treatment centre in Europe, and offers services including diagnosis, treatment and general care for cancer patients, as well as cancer education.
Website: www.christie.nhs.uk Email: [email protected]
Papworth HospitalPapworth Everard, Cambridge, CambridgeshireCB3 8RE. Telephone: 01480 830541
Papworth Hospital is the largest international specialist Cardiothoracic (heart and lung) hospital in the UK and includes the country’s main heart and lung transplant centre. Also provides a Mesothelioma support service.
Website: www.papworthhospital.nhs.uk Email: [email protected]
The Royal Marsden Hospital Fulham Road, London, Greater LondonSW3 6JJ. Telephone: 020 7352 8171
The Royal Marsden, together with its academic partner, The Institute of Cancer Research (ICR), is designated as the UK’s only National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) dedicated solely to cancer. Provides both trials and treatments.
Website: www.royalmarsden.nhs.uk Email: Contact form online
Derriford Hospital Derriford Rd, Plymouth, Devon PL6 8DHTelephone: 01752 202082
Derriford Hospital is a large teaching hospital in Plymouth. It is one of three hospitals approved to conduct Mesothelioma trials.
Website: www.plymouthhospitals.nhs.uk Email: Contact form online
Basingstoke and North Hampshire HospitalAldermaston Road, Aldermaston Road, Basingstoke, Hampshire, RG24 9NA. Telephone: 01256 473 202
Centre for specialist treatment of Peritoneal Mesothelioma. Home to Consultant Colorectal Surgeon Dr. Faheez Mohamed and Hyperthermic Intraperitoneal Chemotherapy (chemo bath).
Website: www.hampshirehospitals.nhs.uk Email: [email protected]
Glenfield HospitalGroby Road, Leicester, Leicestershire. LE3 9QPTelephone: 0116 287 1471
Respiratory and Cardiothoracic Centre, Mesothelioma Centre and home to Mesothelioma UK and Professor Dean Fennell. The specialist lung cancer centre has excellent lung cancer survival rates and an extremely active research programme.
Website: www.leicestershospitals.nhs.uk
Guy’s HospitalSt. Thomas’ Street, London, Greater LondonSE1 9RT. Telephone: 020 7188 7188
Guy’s Hospital offers some of the top cancer specialists in the country, the very latest state-of-the-art facilities and pioneering treatments, thanks to their extensive research programmes.
Website: www.guysandstthomas.nhs.uk Email: [email protected]
St. Bartholomew’s HospitalWest Smithfield, London, Greater LondonEC1A 7BE. Telephone: 020 7377 7000
St. Bartholomew’s Hospital (Barts), is a leading, internationally renowned teaching hospital based in the City of London. It is the centre for Mesothelioma research (UK wide). Home to Dr. Rudd and Jeremy Steele (Chairman of Mesothelioma UK).
Website: www.bartshealth.nhs.uk Email: Contact form online
0800 038 6767www.asbestosjustice.co.uk
Asbestos Justice, Douglas House, 117 Foregate Street Chester, Cheshire, CH1 1HE
Rest assured, you’re in safe hands.
Keep in touch on Facebook: www.facebook.com/asbestosjustice
Follow us on Twitter: www.twitter.com/asbestosjustice
Connect with us on LinkedIn: www.linkedin.com/company/asbestos-justice
Asbestos Justice is a trading style of Oliver & Co Solicitors Ltd Douglas House, 117 Foregate Street, Chester, Cheshire, CH1 1HE. Telephone 0800 038 6767
